Front. Cardiovasc. Med.Frontiers in Cardiovascular MedicineFront. Cardiovasc. Med.2297-055XFrontiers Media S.A.10.3389/fcvm.2023.1208579Cardiovascular MedicineRetractionRetraction: STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetesFrontiers Editorial Office*
Approved by: Ngan F Huang, Stanford University, United States
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
section-at-acceptanceCardiovascular Biologics and Regenerative MedicineA Retraction of the Original Research Article STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes By Joladarashi D, Zhu Y, Willman M, Nash K, Cimini M, Thandavarayan RA, Youker KA, Song X, Ren D, Li J, Kishore R, Krishnamurthy P and Wang L (2022). Front. Cardiovasc. Med. 8:798091. doi: 10.3389/fcvm.2021.798091
The journal retracts the 13 January 2022 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication concerns were identified in Figures 3D, 4E, 6. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Cardiovascular Medicine and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.